|
J Biol Chem, Vol. 275, Issue 19, 14139-14146, May 12, 2000
Hypoxic Induction of Prolyl 4-Hydroxylase (I) in Cultured
Cells*
Yuji
Takahashi §,
Shigeru
Takahashi ,
Yuko
Shiga,
Tatsuya
Yoshimi, and
Takashi
Miura
From the Laboratory of Environmental Molecular Physiology, School
of Life Science, Tokyo University of Pharmacy and Life Science,
1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan
 |
ABSTRACT |
Accumulated evidence indicates that hypoxia
activates collagen synthesis in tissues. To explore the molecular
mechanism of activation, we screened genes that are up-regulated or
down-regulated by hypoxia. Fibroblasts isolated from fetal rat lung
were cultured under hypoxia. Differential display technique showed that
the mRNA level of prolyl 4-hydroxylase (PH) (I), an active
subunit that catalyzes the oxygen-dependent hydroxylation
of proline residue in procollagen, increased 2-3-fold after an 8-h
exposure to hypoxia. This elevated level was maintained over 40 h
and returned to the basal level after reoxygenation. The transcription
rate, protein level, and hydroxyproline content (an indicator of the
prolyl hydroxylation) were all elevated by hypoxic culture. Analysis of
the promotor region of PH (I) gene indicated that a motif similar to
hypoxia-responsive element (HRE) of hypoxia-inducible genes such as
erythropoietin, was identified within a 120-base pair sequence upstream
of the transcription start site. Luciferase reporter assay and
mutational analysis showed that a site similar to the HRE in this motif
is functionally essential to hypoxic response. Electrophoretic mobility
shift assay revealed that hypoxia-inducible factor-1 was stimulated and
bound to the PH (I) HRE upon hypoxic challenge. Our results indicate
that PH (I), an essential enzyme for collagen synthesis, is a target
gene for hypoxia-inducible factor-1.
 |
INTRODUCTION |
Restricted oxygen availability is a feature of many physiologic
and pathologic conditions, including high altitude residence, fetal
development in the uterus, pulmonary fibrosis, wounded tissue, and
neoplasm (1). Systemic and cellular responses to reduced oxygen tension
(hypoxia) are initiated by activation and/or inactivation of gene
expression. Hypoxia-inducible factor-1
(HIF-1),1 which was
originally found to be a critical mediator for the inducible expression
of the erythropoietin (Epo) gene by hypoxia (2), is a heterodimer
composed of HIF-1 and arylhydrocarbon receptor nuclear translocator
(ARNT). HIF-1 and ARNT retain a basic helix-loop-helix domain and a
Per-ARNT/aryl hydrocarbon receptor Sim domain in their N termini (2).
Hypoxia induces stabilization of HIF-1 (3), heterodimerization of
HIF-1 and ARNT (4), and the binding of the heterodimer to the
hypoxia-responsive element (HRE) in the regulatory region of the target
genes with the transcriptional coactivator p300/CREB-binding protein
(5). Although posttranscriptional mechanisms may contribute to the induction of hypoxia-sensitive genes, activation of the HIF-1 complex
is an important step leading to hypoxia-mediated induction of
glycolytic enzymes (6-9), Epo (2), vascular endothelial growth factor
(10), and tyrosine hydroxylase (11).
In the remodeling of the small muscular pulmonary artery observed in
hypoxia-induced pulmonary hypertension, type I collagen is actively
synthesized and accumulated in the media and the adventitia of the
artery (12). Recent studies have revealed that in vivo exposure of rats to hypoxia increases prolyl hydroxylase activity in
skeletal muscle (13) and increases the concentration of collagenous proteins in cardiac muscle (14). Moreover, in vitro exposure of rat mesangial cells (15) and dermal fibroblasts (16) to hypoxia
results in the enhancement of type IV collagen protein level and type I
procollagen mRNA level, respectively. These observations indicate
that systemic and cellular hypoxia modulates collagen synthesis in
several types of cells. Synthesis of collagen molecules can be
regulated at several steps (17). After translation, procollagens are hydroxylated on proline residues at the endoplasmic reticulum and
form stable triple-helical trimers. The secreted procollagen trimer is
proteolytically cleaved at both N-and C-propeptides in the
extracellular space, where collagen trimers polymerize and are
deposited nonenzymatically. These sequential steps of collagen
synthesis and hypoxic effects on several stages in the expression of
multiple types of collagen genes imply that hypoxic regulatory factors
may be involved in common reactions during the collagen synthesis process.
To explore the molecular mechanism, we screened hypoxia-responsive
genes in isolated fetal rat lung fibroblasts using the differential
display method. We subsequently found that prolyl 4-hydroxylase (PH)
(I), an active subunit that catalyzes oxygen-dependent hydroxylation of proline residue in procollagen, is up-regulated by
hypoxia via HIF-1 transcription factor complex.
 |
EXPERIMENTAL PROCEDURES |
Cell Culture--
Fibroblasts were isolated from the fetal rat
lung at 19 days of gestation (18). IMR-90 and WI-38, human fetal lung
fibroblast cell lines, were obtained from the RIKEN Cell Bank (Tokyo,
Japan). These cells were maintained in Dulbecco's modified Eagle's
medium (DMEM) supplemented with 10% fetal calf serum (FCS), 100 units/ml penicillin, 100 µg/ml streptomycin, 1 mM sodium
pyruvate, 0.1 mM minimum essential medium nonessential
amino acid, 1× minimum essential medium vitamin, and 15 mM
HEPES (pH 7.4). Fetal rat lung fibroblasts between the 20th and 25th
passages were used for the experiments. The mouse hepatoma cell lines
Hepa-1c1c7 (Hepa-1) and its ARNT-defective derivative, Hepa-c4, were
generously supplied by O. Hankinson. Hepa-c4 cells lack ARNT function
and also fail to express the ARNT protein (19). These cells were cultured in the minimal essential medium- without nucleosides (Life
Technologies, Inc.) supplemented with 10% FCS, 100 units/ml penicillin, 100 µg/ml streptomycin, 2 mM glutamine, and
15 mM HEPES (pH 7.4). At subconfluence, cells were exposed
to hypoxia or treated with chemicals. Exposures of cells to hypoxia
were performed as described previously (9). In some experiments, 200 µM ascorbic acid was added to the medium.
Differential Display and Transcriptional Run-on Assay--
We
followed the fluorescent differential display method developed by Ito
et al. (20) with several modifications, as described in a
previous paper (9). Transcriptional run-on assay was performed as
described previously (9). The amount of PH (I) transcript was
standardized by comparison with the -actin signal.
RNA Blotting--
Probes for RNA blot analysis were prepared by
reverse transcription-polymerase chain reaction with rat total RNA
extracted from the lung as mentioned previously (21). The following
sense and antisense primers were used: rat PH (I),
DDBJ/EMBL/GenBankTM accession no. X78949, nucleotides
103-122, and nucleotides 1085-1066. RNA blotting was performed as
described previously (22). After analysis of the PH (I) mRNA
level, the probe was stripped with a low salt wash at 90 °C. The
membrane was reprobed for 28 S rRNA. The intensity of the mRNA was
normalized to the 28 S rRNA signal (23).
Preparation of Cell Homogenate--
The fibroblast monolayer was
washed three times with phosphate-buffered saline (PBS), then scraped
and pelleted by centrifugation at 100 × g for 5 min at
4 °C. Cell pellets were washed once with PBS. The cell pellets were
suspended in a 10× volume of 0.2 M NaCl, 0.1 M
glycine, 20 mM Tris-HCl (pH 7.5 at 4 °C) containing 0.1% Triton X-100, 0.2 mM phenylmethylsulfonyl fluoride,
0.5 mM dithiothreitol and kept on ice for 10 min, followed
by homogenization in a Potter-Elvehjem homogenizer at 1200 rpm with 10 up-and-down strokes. The homogenate was analyzed for PH by protein blotting.
Protein Blotting--
Protein blotting was performed as
mentioned previously (9) with some modifications. For PH detection,
equivalent amounts of protein from each sample were subjected to 10%
SDS-polyacrylamide gel electrophoresis and then electrically
transferred overnight at 25 °C from the gel to nitrocellulose
membranes. The blots were incubated with mouse anti-rat PH
monoclonal antibody (Fuji Chemical, Toyama, Japan) at 0.3 µg IgG per
ml of 0.1% Tween 20-Tris-buffered saline (TTBS) for 1 h at
25 °C, and then rinsed three times in TTBS for 15 min. The blotted
membranes were probed with horseradish peroxidase-conjugated goat
anti-mouse IgG at a dilution of 1:3000 for 1 h. After four washes
with TTBS, antibody-antigen complexes were detected using an enhanced
chemiluminescence detection kit (Amersham Pharmacia Biotech) according
to the manufacturer's protocol.
Quantification of Hydroxy Proline, DNA, and Protein--
To
analyze hydroxy proline in the culture medium, fibroblasts at
subconfluency were cultured in 10% FCS-DMEM with or without 200 µM ascorbic acid under either 20 or 0% O2
for 24 h. For the next 24 h, cells were maintained in 0.1%
FCS-DMEM with or without 200 µM ascorbic acid under
either 20 or 0% O2. The culture medium was collected and
hydrolyzed in 6 N HCl for 16 h at 116 °C. To analyze the hydroxy proline in the cells and cell-associated matrix, subconfluent fibroblasts were cultured for 8 days. The culture medium
was changed every other day. After three washes with PBS, the cell
layer was harvested by scraping and hydrolyzed. The 4-hydroxy proline
in the hydrolyzate was determined by the colorimetric method (24, 25).
The DNA content of the cell homogenate was assayed by the
fluorochrometric method using DNA-binding fluorochrome Hoechst 33258 (26). The protein content was measured by the colorimetric method using
the Pierce BCA protein assay kit, according to the manufacturer's
manual. BSA was used as the standard.
Transient Transfections and Reporter Gene Assays--
The rat
genomic library was screened against rat PH (I) cDNA probe
containing a 5'-untranslated region. One clone covering from 1.9 kb
5'-upstream of the transcription starting site to the first exon was
selected to analyze responses of PH (I) gene to
hypoxia.2 A region from -1.9
kb to +68 bases (transcription start site was transiently determined by
the 5'-RACE method, Clontech, Palo Alto, CA) was ligated to Photinus
pyralis luciferase reporter vector (pGL3-basic, Promega, Madison, WI)
and designated prPHLUC19. Deletion mutants of prPHLUC19 containing
regions from -117 to +68 and from -68 to +68, were constructed and
designated prPHLUC(-117) and prPHLUC(-68), respectively. Mutation of
the putative HRE sequence 5'-CGCACGTA-3' (27) at position -86 to -79
in the sense DNA strand of the prPHLUC(-117) plasmid by replacement of
the bases ACG with TTT to construct prPHLUC(-117)m was introduced by
using the QuikChangeTM site-directed mutagenesis kit
(Stratagene, La Jolla, CA). All constructs were verified by DNA
sequencing. Subconfluent cultures of rat lung fibroblasts, Hepa-1
cells, and Hepa-c4 cells were cultured in 60-mm dishes. When the
cultures reached subconfluence, cells were transfected by
PH (I)-luciferase chimeric plasmids, the promotor-less luciferase
plasmid (a negative control vector, pGL3-basic, Promega, Madison, WI)
or the SV40-promoter/enhancer containing luciferase plasmid (a positive
control vector, pGL3-control) concomitantly with 0.1 µg of pRL-SV40,
an internal control plasmid containing Renilla reniformis luciferase
gene. Test plasmid (0.45 pmol), 5 µl of FuGENE6 trasfection reagent
(Roche Molecular Biochemicals), and 95 µl of serum-free medium
complex were added to the cultured cells. After 24 h incubation,
cells were exposed to hypoxic gas for 16 h, and then lysed. Cell
lysates were used to determine luciferase activity using Lumat LB 9501 (EG & G Berthold, Bad Wildbad, Germany).
Preparation of Whole Cell Extracts and Electrophoretic Mobility
Shift Assay--
The cell monolayer was washed once with PBS and then
scraped. After centrifugation at 100 × g for 5 min at
4 °C, cell pellets were washed once with PBS, quickly frozen in
liquid nitrogen for more than 5 min, and thawed on ice for 5-10 min
with a 5-fold cell-packed volume of cell lysis buffer (50 mM HEPES-KOH, pH 7.9, 420 mM KCl, 1.5 mM MgCl2, 0.2 mM EDTA, 1 mM dithiothreitol, 1 mM sodium orthovanadate,
1× CompleteTM (protease inhibitor mixture, Roche Molecular
Biochemicals), 20% glycerol). Cells were lysed at 4 °C by multiple
(20) passages through a 26 gauge needle, followed by centrifugation at
12000 × g for 15 min at 4 °C. The supernatants were
frozen in liquid nitrogen and stored at -85 °C until use. Mouse Epo
3'-enhancer oligonucleotide (5'-GCC CTA CGT GCT GCC TCG CAT GGC-3')
(27), PH (I) 5'-enhancer oligonucleotide (from -91 to -74, numbered with the transcription start site as +1; 5'-CTG AGC GCA CGT
AGC GAG-3'), and PH (I)-M oligonucleotide (5'-CTG AGC GCT
TTT AGC GAG-3') were used as probes or competitors. Both
strands of oligonucleotide probes were labeled with
[ -32P]ATP (111 TBq/mmol) and T4 polynucleotide kinase
and then annealed in 20 mM Tris-HCl, pH 7.5, 10 mM MgCl2, and 50 mM NaCl by heating at 80 °C for 5 min followed by gradual cooling to 25 °C over 60 min. The annealed probes were purified by passing them through an
NAP-column (Amersham Pharmacia Biotech). A typical DNA binding reaction
was carried out by mixing 15 µg of cell extract with 20 µl of DNA
binding buffer (10 mM Tris-HCl, pH 7.5, 50 mM
KCl, 1 mM MgCl2, 0.5 mM EDTA, 5 mM dithiothreitol, 280 ng of sonicated poly(dI-dC), 1×
CompleteTM) for 5 min at 25 °C. Probes (20 fmol) and
competitors (2 pmol) were added and incubated for a further 10 min at
25 °C. Reaction products were electrophoresed at 4 °C on 5%
polyacrylamide in 30 mM Tris/30 mM boric acid,
0.3 mM EDTA (pH 7.3 at 20 °C). For supershift assay, 1 µg of monoclonal anti-HIF-1 antibody (H1 67, Novus Biochemical,
Littleton, CO) or anti-Flag-epitope tag antibody as control (M5,
Sigma), were incubated with 15 µg of whole cell extract at 4 °C
for 90 min.
Statistics--
Analyses of significant differences between data
sets were performed by the use of Student's t test or
Welch's t test after analysis of variance. Values of
p < 0.05 were considered statistically significant.
 |
RESULTS |
Differential Display--
Gene products up-regulated or
down-regulated by a 16-h exposure of fetal rat lung fibroblasts to 0%
O2 were screened by the differential display technique
using 104 combinations of arbitrary primers and anchor primers.
Polymerase chain reaction with arbitrary primer 5'-TTTTGGCTCC-3' and
fluorescein isothiocyanate-labeled anchor primer 5'-GT15VA
amplified a fragment at base pair 350, where the intensity from hypoxic
cells is higher than that from normoxic cells (Fig.
1, left). This difference was
confirmed by amplification with the same pair of primers using
[35S]dCTP (Fig. 1, right). Cloning of this
band combined with a computer search of sequence similarity revealed
that this amplified DNA was the 3'-fragment of PH (I) cDNA.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 1.
Differential display. Subconfluent
cultures of fetal rat lung fibroblasts were either maintained under
20% O2 (N) or exposed to 0% O2
(H) for 16 h. Complemental DNA was reverse-transcribed
from the total RNA extracted from the cells. Products of polymerase
chain reaction amplification with arbitrary primer 5' TTTTGGCTCC-3' and
fluorescein isothiocyanate-labeled anchor primer 5'-GT15VA
(V is a mixture of A, C, and G) were separated on a DNA sequencer, and
the fragment pattern was analyzed by fragment manager software
(left panel). A peak (left panel,
arrow), showing different abundances between 20%
O2 culture and 0% O2 culture, was confirmed by
polymerase chain reaction amplification with 35S-labeled
nucleotide and autoradiography of the fragment separated on sequence
gel (right panel). The corresponding band, indicated by the
arrow, was subjected to cloning and sequencing. Positions of
simultaneously run molecular mass markers are shown on both
sides.
|
|
Kinetics of Increases in PH (I) mRNA Levels after
Hypoxia--
To examine the response of PH (I) gene expression to
low oxygen culture, the steady state level of PH (I) mRNA was
determined by RNA blot analysis. Fibroblasts at subconfluency were
cultured for 16 h at various concentrations of O2 from
20 to 0%. The PH (I) mRNA level increased in a hypoxic
stress-dependent manner (Fig. 2A). The PH (I) mRNA
signal, normalized to 28 S rRNA, increased to 1.3-fold the control
after 3% O2 culture. This response was enhanced by hypoxic
conditions of 2 to 0% O2. Increases in the PH (I)
mRNA level after hypoxia reached their peak at 0% O2,
a value 3.0-fold that of the 20% O2 control. Time
dependence was determined in the cells cultured under 0%
O2 (Fig. 2B). An increase in the PH (I)
mRNA level became evident after 8 h hypoxia and reached its
maximum after 16 h. This increased level was maintained for
40 h of hypoxic exposure. After fibroblasts were returned from
16 h of hypoxic culture to normoxic atmosphere (reoxygenation), the elevated level of PH (I) mRNA decreased slightly after 4 h reoxygenation and returned to the prehypoxic value after 24 h of
reoxygenation.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 2.
Kinetics of the
PH (I) mRNA level after hypoxia.
A, after fetal rat lung fibroblasts reached subconfluence
under normoxia, cells were maintained at 20% O2
(inset, lane 1) or exposed to hypoxia (5-0%
O2; inset, lanes 2-7) for 16 h. Following
extraction of total RNA, the steady state level of PH (I) mRNA
was determined by the RNA blotting method (inset,
top). Radioactivity was estimated as mentioned under
"Experimental Procedures" and normalized to the 28 S rRNA signal
(inset, bottom) and then expressed as a level relative to
the control. B, subconfluent fibroblasts were either
maintained at 20% O2 or exposed to 0% O2 for
various lengths of time, as indicated. In certain experiments, after
16 h in 0% O2, fibroblasts were returned to 20%
O2 for the indicated times (reoxygenation). The steady
state level of PH (I) mRNA was analyzed and expressed as in
A.
|
|
IMR-90 and WI-38, human fetal lung fibroblast cell lines, also showed
increases in the PH (I) mRNA level by 2.5-3.0-fold the normoxic
control in response to 16 h of hypoxic exposure (data not shown).
Run-on Transcription Analysis--
The increase of PH (I)
mRNA levels by hypoxic cultures pointed to a transcriptional effect
on PH (I) expression. To assess this aspect, we measured PH (I)
gene transcription in isolated nuclei. The transcriptional rate of
PH (I), normalized to the -actin signal, significantly increased
to 2.2-fold (p < 0.05) and 3.3-fold (p < 0.05) of the normoxic control after 4 and 8 h of exposure to
0% O2, respectively (Fig.
3). Transcription of -actin appeared
to be unchanged under the same conditions. LDH-A, a positive control
gene (6), showed 1.4- and 1.8-fold (p < 0.05)
increases in the relative transcription rate after 4 and 8 h of
0% O2 exposure, respectively. Vector DNA did not show any signal.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 3.
Transcriptional rate of
PH (I) mRNA. Nylon membranes binding
plasmid DNA of PH (I), LDH-A, and -actin (top) were
hybridized with 32P-labeled run-on transcripts from 1 × 107 nuclei isolated from fibroblasts cultured under
normoxia or hypoxia for 4 or 8 h. As the control DNA, pBluescript
KS bound to nylon membrane was hybridized with nascent
32P-labeled RNA as above. Radioactivities of newly
transcribed PH (I) and LDH-A levels were normalized to -actin and
expressed as increases relative to control levels (bottom).
Means and standard errors from three experiments are shown.
Statistically significant differences between normoxia and hypoxia are
shown (*, p < 0.05).
|
|
Levels of PH Protein and Hydroxyproline Residue--
To
determine the protein level of PH in fibroblasts, we probed the
whole cell homogenate by protein blotting for the presence of PH
protein. Anti-rat PH monoclonal antibody detected a band at 63,000 daltons in the fibroblasts, which co-migrated with authentic PH (I)
(Fig. 4A). After 4 h of
exposure to 0% O2, the protein level of PH
significantly increased to 1.3-fold (p < 0.05) the control level (Fig. 4B). The protein level reached its peak
after 24 h of 0% O2 exposure, which was 1.9-fold
(p < 0.05) the control. The elevated level was
maintained after 32 h exposure to hypoxia. This protein response
to hypoxic culture was similar to that observed for mRNA
levels.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 4.
Protein level of
PH . Subconfluent fibroblasts were either
maintained in 20% O2 or exposed to 0% O2 for
4-32 h. The PH protein levels were determined by the protein
blotting method using anti-PH antibody as described under
"Experimental Procedures." Lane S represents authentic
PH protein, and lanes 1-6 represent samples harvested
from 20% O2 and from 0% O2 for 4, 8, 16, 24, and 32 h, respectively (A). On the right,
migration of the simultaneously run molecular mass marker is shown
(arrowheads from the top down represent origin and 97.4, 66, 45, 31, and 21.5 kDa, respectively). Densitometric analysis was
performed, and intensity relative to 20% O2 control was
expressed. Means and standard errors from three experiments are shown
(B). Differences between the control (0 h) and each hypoxic
sample (4, 8, 16, 24, and 32 h) were statistically significant (*,
p < 0.05).
|
|
Hydroxylation of proline residue in procollagen occurs in the
endoplasmic reticulum and is important for stabilizing the procollagen trimer. Hydroxylated procollagen is assembled for secretion from the
cell to the culture medium, in which the C- and N-propeptides of
procollagen are cleaved enzymatically, resulting in deposition of
collagen polymers on the cell surface. To assess the in vivo hydroxylation activity, fibroblasts were cultured under either normoxia
or hypoxia in the presence or absence of ascorbic acid. We determined
the levels of hydroxy- proline residue secreted from fibroblasts into
the medium over 24 h. With the addition of ascorbic acid, hypoxic
culture had no significant effect on the hydroxyproline content of the
conditioned medium (Fig. 5A). Under normoxic culture, ascorbic acid depletion decreased the hydroxyproline content of the medium to 7% of the ascorbic
acid-sufficient culture. Interestingly, without ascorbic acid, hypoxic
culture restored the hydroxyproline level from 7 to 58% of ascorbic
acid-supplemented and normoxic cultures. We analyzed the hydroxyproline
residue that had accumulated in the cell or cell-associated matrix
during the 8-day confluent culture period. Ascorbic acid and hypoxic culture affected the hydroxyproline level in the cell and cell associated matrix, in the same pattern as was observed in the culture
medium (Fig. 5B). These results indicate that
hypoxia-induced accumulation of PH (I) mRNA leads to elevated
protein levels, which then contribute to the maintenance of
hydroxylation in ascorbic acid-supplemented cultures as well as to
elevation of hydroxylation in ascorbic acid-deficient cultures.

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 5.
The hydroxy proline content. Fibroblasts
were grown in 10% FCS-DMEM until the culture reached confluent cell
density. To analyze hydroxy proline in the culture medium
(A), the culture medium was replaced by 0.1% FCS-DMEM,
followed by 1 day of culture with or without 200 µM
ascorbic acid (ASC) under either 20 or 0% O2.
Hydroxy proline content in the culture medium was determined as
mentioned under "Experimental Procedures." To analyze the hydroxy
proline in the cells and cell-associated matrix (B),
subconfluent fibroblasts were cultured for 8 days. The culture medium
was changed every other day. After three washes with PBS, the cell
layer was harvested by scraping and hydrolyzed, and the level of the
4-hydroxy proline in the hydrolyzate was determined. The data are
expressed as nmol of hydroxy proline per µg of DNA, and
bars represent 1 S.D. from three independent experiments.
Significant differences between the ascorbate-supplemented normoxic
culture and ascorbate-deficient or hypoxic cultures are indicated (*,
p < 0.05).
|
|
Effects of HIF-1 Inducers and Mitochondrial Inhibitors on the
PH (I) mRNA Level--
Glucose transporter 1 is up-regulated by
depletion of either ATP or oxygen (28). HIF-1 is a transcription factor
that regulates hypoxic induction of a variety of genes.
CoCl2 and desferroxamine (Des), an iron chelator, can mimic
the HIF-1 response to hypoxia (29). To determine whether the HIF-1
related pathway or ATP depletion in mitochondria is involved in the
up-regulation of PH (I) by hypoxia, HIF-1 inducers (CoCl2
and Des) and mitochondrial inhibitors (rotenone, azide, and cyanide)
were added to the fibroblast cultures. Total RNA was extracted from
cells that were treated with chemicals for 16 h and then the
PH (I) mRNA level was determined by RNA blotting analysis.
CoCl2 (50-200 µM) and Des (50-200
µM) increased the PH (I) mRNA level by
1.8-4.7-fold in a dose-dependent manner (Fig.
6). Rotenone (0.25 and 2.5 µM), NaN3 (1 and 10 µM), and
cyanide (3-300 µM) increased the PH (I) mRNA up to
1.3-fold. This increase was far less than that of hypoxic
induction.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 6.
Effects of CoCl2, desferroxamine,
and mitochondrial inhibitors on PH (I) mRNA
level. When fibroblast culture reached subconfluence,
CoCl2 (50-200 µM), Des (50-200
µM), rotenone (0.25 and 2.5 µM),
NaN3 (1 and 10 µM), and KCN (3-300
µM) were added. After 16 h of culture under 20%
O2, cells were harvested and analyzed for steady-state
PH (I) mRNA level by RNA blotting. The PH mRNA levels were
normalized to 28 S rRNA. Levels relative to the control are
shown.
|
|
Response of the HIF-1-defective Mutant Cell to
Hypoxia--
Hepa-c4, the ARNT-defective cell, and Hepa-1, its wild
type cell, were exposed to 1, 2, and 20% O2 for 16 h,
and analyzed for PH (I) response. The level of PH (I) mRNA in
Hepa-1 cells was apparently enhanced (Fig.
7). However, PH (I) mRNA levels in
Hepa-c4 cells did not change under hypoxic stress. This result indicates that ARNT may be an essential transcription factor subunit for hypoxic induction of PH (I) mRNA in Hepa-1 cells.

View larger version (61K):
[in this window]
[in a new window]
|
Fig. 7.
Response of ARNT-defective cell to hypoxic
stress. The mouse hepatoma cell (Hepa-1) and its ARNT-defective
mutant (Hepa-c4) were exposed to hypoxia (2 and 1% O2) for
16 h. Following extraction of total RNA, the steady-state level of
PH (I) mRNA was determined by RNA blotting (top).
Ethidium bromide staining of total RNA separated in agarose gel by
electrophoresis is shown (bottom).
|
|
Transcriptional Activity of the PH (I) Promoter--
To assess
regulatory elements that delineate hypoxic up-regulation of the
PH (I) gene, we screened the rat genomic library against a rat
PH (I) cDNA probe containing a 5'-untranslated region. A clone
covering from 1.9 kb 5' upstream of the transcription starting site to
the first exon2 was selected to analyze responses of the
P4H (I) gene to hypoxia (these DNA sequences are not shown, but they
have been deposited in the GenBankTM under accession number
AF197928). A 1.9-kb fragment (-1.9 kb to +68 bases) of rat PH (I)
promotor region was cloned in front of luciferase, and the resulting
construct (prPHLUC19, Fig. 8A) was transiently transfected in fibroblasts. Under normoxia, the transfected fibroblasts exhibited 88 times higher luciferase activity than cells transfected by promoterless Luc vector (pGL3-Basic), but 9 times lower activity than the SV40 promoter/enhancer vector (pGL3-Cont.) (Fig. 8B). This suggests that the 1.9-kb
promoter region has sufficient promoter activity to invest the hypoxic effects on the gene. Exposure of the transfected fibroblasts to hypoxia
for 16 h stimulated luciferase expression by 5.5-fold (Fig.
8B). No significant effect was observed after hypoxic
culture of cells transfected with promoter-less or SV40 vectors. Hepa-1 and its ARNT-defective mutant cell, Hepa-c4, were transfected with
prPHLUC19. Hepa-1 showed a 3.7-fold induction of luciferase after
16 h of hypoxic culture (Fig. 8B). In contrast,
exposure of Hepa-c4 to hypoxia did not affect luciferase expression
(Fig. 8B). These results strongly suggest that the PH (I)
promoter may contain the hypoxia-responsive consensus sequence, which
the HIF-1 ·ARNT complex targets. Search for potential binding sites
in the promoter region revealed one binding site (-79 to -86)
matching the consensus for HIF-1 ·ARNT (C/G/T)ACGTGC(G/T) (30) on
the antisense strand. A CACAG sequence (31), which seems to be
necessary for hypoxic inducibility, was also identified from position
-67 to -71 on the antisense strand. To define the promoter region
that confers hypoxia responsiveness to PH (I), we determined the
luciferase activity of 5'-deletion constructs (Fig.
9A). The prPHLUC(-117), which
included the HRE consensus sequence, showed a response to hypoxic
exposure: 5.9-fold induction after 16 h of transfection to fetal
lung fibroblasts (Fig. 9B). However, the shorter construct, prPHLUC(-68), which lacked the HRE consensus, did not change
luciferase activity after hypoxic culture. This HRE involvement in the
PH (I) response to hypoxia was further supported by a complete loss
of hypoxic induction in a mutated chimera luciferase reporter,
prPHLUC(-117)m (Fig. 9B). After 16 h of hypoxia,
prPHLUC(-117) showed a 6.0-fold induction in Hepa-1 cells but no
change in Hepa-c4 cells (Fig. 9B).

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 8.
Stimulation of PH (I)
promoter activity by hypoxia. A, structures of reporter
gene constructs. A fragment of base pairs -1904 to +68 derived from
the PH (I) promoter (prPHLUC19) was cloned in front of the Photinus
luciferase gene. B, transient expression assay. Hepa-1
cells, Hepa-c4 cells, and fetal rat lung fibroblasts were transfected
by either PH (I)-luciferase chimeric plasmids or the promotor-less
luciferase plasmid (pGL3-basic) or the SV40-promoter/enhancer
containing luciferase plasmid (pGL3-Control) concomitantly with
pRL-SV40, an internal control plasmid containing the Renilla luciferase
gene. After 16 h of exposure of the cells to normoxia (20%
O2, open bars) or hypoxia (1% O2
for Hepa cells, 0% O2 for the fibroblasts; closed
bars), activities of both luciferases in the cell lysate were
determined. The activity of Photinus luciferase was normalized to
Renilla luciferase and is expressed as relative luciferase activity
(mean ± S.D. of at least three independent experiments).
Luciferase activities in hypoxic cells relative to those in the
normoxic cells are expressed as fold induction, shown at the
right.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 9.
Analyses of PH (I)
promoter by deletion and mutation. A, structures of
reporter gene constructs. The 5'-region of prPHLUC19 was deleted to
make prPHLUC(-117) and prPHLUC(-68), which cover base pairs -117 to
+68 and base pairs -68 to +68, respectively. The expansion shows a
sequence containing the putative HRE. This sequence was mutated in
prPHLUC(-117)m. B, transient expression assay. Hepa-1
cells, Hepa-c4 cells, and fetal rat lung fibroblasts were transfected
by either PH (I)-luciferase chimeric plasmids, the promotor-less
luciferase plasmid (pGL3-basic), or the SV40-promoter/enhancer
containing luciferase plasmid (pGL3-Control) concomitantly with
pRL-SV40, an internal control plasmid, which contains the Renilla
luciferase gene. After 16 h of exposure of the transfected cells
to normoxia (20% O2) or hypoxia (1% O2 for
Hepa cells, 0% O2 for the fibroblasts), luciferase
activity was determined and corrected for transfection efficiency
according to the Renilla luciferase activity. Luciferase activities in
hypoxic cells relative to those in normoxic cells are indicated. All
values represent mean ± S.E. of at least three independent
experiments.
|
|
DNA Binding Activity to the PH (I) HRE--
To assess whether
the HRE consensus sequence identified in the PH (I) promoter was the
target of HIF-1, whole cell extracts prepared from Hepa-1 cells were
analyzed by electrophoretic mobility shift assays (Fig.
10, lanes 1-7). The
PH (I) probe detected hypoxia-specific DNA binding activity (HIF-1)
in Hepa-1 cells (Fig. 10, lane 2). This band was absent in
normoxic cells (Fig. 10, lane 1). Constitutively expressed
DNA binding activity was detected in Hepa-1 cells cultured under both
normoxia and hypoxia (Fig. 10, lanes 1 and 2, Con). This hypoxically induced interaction of the PH (I) probe
was also observed in whole cell extract prepared from fibroblasts (Fig. 10, lane 14), but no hypoxic induction of DNA binding was
identified in whole cell extract from ARNT-defective Hepa-c4 cells
(lane 12). The specificity of the interaction between the
probe and hypoxia-induced factors was tested by competition with
nonradioactive oligonucleotides. An excessive amount of cold PH (I)
probe (100× labeled probe) inhibited the binding of the constitutive
and inducible complexes (Fig. 10, lane 3). Addition of a
mutated PH (I) oligonucleotide (PH-M) did not compete with labeled
PH (I) probe. Competition with cold oligonucleotides corresponding to
the HRE present in the Epo enhancer (Fig. 10, lane 4, EPO)
suggested a binding of the HIF-1 ·ARNT complex to PH (I) probe.
To further characterize the hypoxia-induced complexes, whole cell
extracts were incubated with a monoclonal antibody to HIF-1 before
the mobility shift assays. Supershift assays showed that HIF-1
interacts with the HRE sequence of PH (I) gene (Fig. 10, lane
6). However, Flag monoclonal antibody used as control did not
affect the HIF-1 binding to the PH (I) probe (Fig. 10, lane
7).

View larger version (55K):
[in this window]
[in a new window]
|
Fig. 10.
Analysis of HIF-1 DNA binding activity by
mobility shift assay. Whole cell extracts prepared from Hepa-1
cells, Hepa-c4 cells, and fetal rat lung fibroblasts, maintained under
normoxia (N) or hypoxia (H) for 4 h, were
incubated with radioactive PH (I) probe (PH) in the
absence or presence (100-fold molar excess) of unlabeled PH (I),
erythropoietin (EPO), or mutated PH (I) (PH-M)
oligonucleotides. Position of complexes containing constitutive
(Con) or HIF-1 binding activity are indicated. Monoclonal
antibodies against HIF-1 (H1a67) and Flag tag sequence as control
antibody were incubated with whole cell extracts, and the DNA, protein,
and antibody complex (supershift band) was analyzed. Sequences for
probe or competitor and HRE consensus are shown in the bottom
panel.
|
|
 |
DISCUSSION |
In the late 1970s, Levene and Bates (32), and Turto et
al. (33) reported that hypoxia increased enzymatic activity of procollagen prolyl hydroxylase. However, the regulatory step of the
enzymatic activity remained unclear. In this report, we have shown that
exposure of fetal lung fibroblasts to hypoxia activates the PH (I)
gene through the HIF-1 transcription factor complex, the binding of
which to the hypoxic responsive element in the 5'-flanking region of
the PH (I) gene leads to an increase in transcription rate, steady
state level of mRNA, cellular protein level, and hydroxy proline
level in the ascorbic acid-deficient culture.
Several pathways have been proposed for gene induction by hypoxic
stress (1). The transcription factors HIF-1 and HIF-2 (34) (also
known as HLF or EPAS1) play a major regulatory role in hypoxic gene
induction. In addition, nuclear respiratory factor 1 can mediate the
hypoxic signal via a decrease in energy production by
oxidative-phosphorylation (35). Recently, Disher et al. (36) demonstrated that hypoxia up-regulates -enolase gene expression via
destabilization of Sp3, a transcription factor. Unknown factors besides
HIF-1 have also been suggested (37). The present results show that the
mitochondrial inhibitors azide, rotenone, and cyanide do not affect the
PH (I) mRNA level (Fig. 6). In contrast, both cobaltous ion and
Des up-regulate PH (I) gene expression. CoCl2 and Des
mimic HIF-1-mediated hypoxic signals and activate transcription of a
variety of genes that are induced by hypoxic stress (29). Moreover,
mutant cells incapable of producing ARNT, an essential component of
HIF-1 and HIF-2 transcription factor complexes, do not elevate PH (I)
mRNA level and reporter gene activities (Figs. 7 and 8). The
importance of HIF-1 transcription factor complex and hypoxia-responsive
element in the PH (I) gene promoter region were confirmed by the
reporter gene assay and the electrophoretic mobility shift assays
(Figs. 9 and 10). A promoter region covering from 1.9 kb to the
transcription start site, which was ligated to luciferase reporter
vector, mimicked the hypoxia-dependent induction. In that
PH (I) promoter region, there is one HRE core sequence RCGCT and an
adjacent CACAG sequence, which are similar to several known HREs of
genes such as Epo and vascular endothelial growth factor (10, 31, 38).
These results indicated that the HRE core sequence in PH (I) promoter
is functional and primarily responsible for hypoxic enhancement of the
transcriptional rate of the PH (I) gene. The binding of the HIF-1
complex to the PH (I) promoter HRE core sequence was further
supported by supershift of the PH (I)-HRE probe complex by the
addition of a monoclonal antibody against HIF-1 and by competition
in binding between PH (I) and Epo probes in the electrophoretic
mobility shift assays. These data indicate that HIF-1 binding to the
HRE core sequence in the PH (I) promoter is important to hypoxic
up-regulation of the PH (I) gene.
Hypoxia-mediated PH (I) gene expression could be also modulated at
the posttranscriptional level. An increase in the steady state-level of
PH (I) mRNA became evident after 8 h of hypoxic exposure
(Fig. 2), but the protein level of PH was elevated by 4 h
hypoxic exposure (Fig. 4). The fact that the protein response is more
rapid than that of the mRNA, may be ascribed to the stabilization of the PH protein under low oxygen conditions. Exposure of C6 glioma
cells and PC12 cells to hypoxia increases mRNA levels of vascular
endothelial growth factor (39) and tyrosine hydroxylase (40),
respectively. Increases in both stability and transcription rate of
these mRNAs after hypoxic exposure contribute to their elevated
steady state levels. However, the way in which these modifications in
the posttranscriptional steps contribute to the hypoxically activated
expression of the PH (I) gene remains unclear.
In collagen synthesis, PH is a key enzyme, which catalyzes the
formation of 4-hydroxyproline, an essential residue for the folding of
the procollagen polypeptide chains into triple helical molecules (41).
The active enzyme has two kinds of heterotetramers, each having two
pairs of subunits, ( (I))2 2 and ( (II))2 2. The subunits
contain the major portion of the catalytic site (42). The subunit
is identical to the enzyme protein disulfide-isomerase and is produced
in excess of the subunits (42). Thus, the abundance of the subunits restricts enzyme activity. For the catalytic reaction of PH
activity, Fe2+, 2-oxoglutarate, O2, and
ascorbic acid are required. The 2-oxoglutarate is decarboxylated during
hydroxylation, with one atom of the O2 molecule being
incorporated into the succinate, whereas the other is incorporated into
the hydroxyl group formed on the proline residue (41, 42). Although
O2 is a requirement for enzymatic activity, the cell
culture study done by Levene and Bates (32) showed that exposure of
fibroblasts to anoxia (less than 0.1% O2) enhanced
hydroxylation of proline in newly synthesized collagen in the cells.
The present study has shown that the hydroxy proline content is not
affected by hypoxic conditions under ascorbic acid sufficiency (Fig.
5). In the ascorbic acid-deficient culture, hypoxic exposure increased
the hydroxy proline content in comparison with the normoxic culture.
Reducing reagents such as glutathione and cysteine can be substituted
for ascorbic acid to maintain PH catalytic activity in
vitro, even though ascorbic acid is the most efficient reducing
reagent for PH enzymatic reaction both in vitro and in
vivo system (41, 43). In normoxic conditions in the absence of
ascorbate, the oxidative environment would convert Fe2+ to
Fe3+, which would not support normal hydroxylation.
However, under low oxygen, the relative increase in hydroxylation would
be due to the increase in prolyl hydroxylase, as well as a preservation of Fe2+. Taken together, these results suggest that in a
cell culture system, hypoxic culture may not be the rate-limiting
factor in procollagen hydroxylation and may reduce the requirement for
ascorbic acid in prolyl hydroxylation.
Hydroxyproline residue is critical in stabilizing triple-helical
collagen chains. In addition to collagen, more than 10 proteins, including C1q of complement, acetylcholinesterase, pulmonary surfactant proteins A and D, and conglutinin, have collagen-like domains and are
potential substrates for prolyl hydroxylase (41). Secretion of
surfactant protein D is inhibited by 2,2'-dipyridyl, an inhibitor of
prolyl and lysyl hydroxylase (44). In late pregnancy, pulmonary arterial pO2 in the fetus is less than 3% O2 (45),
although synthesis of collagen and surfactant proteins A and D is
active in the lung parenchima (46-48). Certainly, this active
synthesis is essential for the start of ventilation after the
birth. HIF-1 mediated activation of PH (I) may play an important role
in maintenance of prolyl hydroxylation of procollagen and collagenous
protein under low oxygen conditions in the fetal lung.
 |
ACKNOWLEDGEMENTS |
We thank Dr. O. Hankinson for his generosity
in supplying the hepatoma cell lines Hepa-1c1c7 and c4 for the
completion of this work, Allen Michael Meyer for excellent
proofreading, and Dr. M. Joyce-Brady for useful discussion.
 |
FOOTNOTES |
*
This work was supported in part by a grant-in-aid for
scientific research from the Ministry of Education, Science, Sports and
Culture of Japan (to Y. T. and S. T.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF197928.
These authors contributed equally to the completion of this study.
§
To whom correspondence should be addressed. Tel.: 81-426-76-7015;
Fax: 81-426-76-6811; E-mail: yuji@ls.toyaku.ac.jp.
2
S. Takahashi, Y. Takahashi, and T. Miura,
manuscript in preparation.
 |
ABBREVIATIONS |
The abbreviations used are:
HIF, hypoxia-inducible factor;
PH, prolyl 4-hydroxylase;
HRE, hypoxia-responsive element;
ARNT, arylhydrocarbon receptor nuclear
translocator;
Des, desferroxamine;
Hepa-1 cell, Hepa-1c1c7 cell;
FCS, fetal calf serum;
DMEM, Dulbecco's modified Eagle's medium;
TTBS, 0.1% Tween 20-Tris-buffered saline;
PBS, phosphate-buffered saline;
kb, kilobase(s);
CREB, cAMP-response element-binding protein.
 |
REFERENCES |
| 1.
|
Helfman, T.,
and Falanga, V.
(1993)
Am. J. Med. Sci.
306,
37-41[Medline]
[Order article via Infotrieve]
|
| 2.
|
Wang, G. L.,
Jiang, B.-H.,
Rue, E. A.,
and Semenza, G. L.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
5510-5514[Abstract/Free Full Text]
|
| 3.
|
Huang, L. E.,
Gu, J.,
Schau, M.,
and Bunn, H. F.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
7987-7992[Abstract/Free Full Text]
|
| 4.
|
Jiang, B.-H.,
Rue, E.,
Wang, G. L.,
Roe, R.,
and Semenza, G. L.
(1996)
J. Biol. Chem.
271,
17771-17778[Abstract/Free Full Text]
|
| 5.
|
Arany, Z.,
Huang, L. E.,
Eckner, R.,
Bhattacharya, S.,
Jiang, C.,
Goldberg, M. A.,
Bunn, H. F.,
and Livingston, D. M.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
12969-12973[Abstract/Free Full Text]
|
| 6.
|
Firth, J. D.,
Ebert, B. L.,
and Ratcliffe, P. J.
(1995)
J. Biol. Chem.
270,
21021-21027[Abstract/Free Full Text]
|
| 7.
|
Li, H.,
Ko, H. P.,
and Whitlock, J. P., Jr.
(1996)
J. Biol. Chem.
271,
21262-21267[Abstract/Free Full Text]
|
| 8.
|
Semenza, G. L.,
Jiang, B.-H.,
Leung, S. W.,
Passantino, R.,
Concordet, J.-P.,
Maire, P.,
and Giallongo, A.
(1996)
J. Biol. Chem.
271,
32529-32537[Abstract/Free Full Text]
|
| 9.
|
Takahashi, Y.,
Takahashi, S.,
Yoshimi, T.,
and Miura, T.
(1998)
Eur. J. Biochem.
254,
497-504[Medline]
[Order article via Infotrieve]
|
| 10.
|
Levy, A. P.,
Levy, N. S.,
Wegner, S.,
and Goldberg, M. A.
(1995)
J. Biol. Chem.
270,
13333-13340[Abstract/Free Full Text]
|
| 11.
|
Norris, M. L.,
and Millhorn, D. E.
(1995)
J. Biol. Chem.
270,
23774-23779[Abstract/Free Full Text]
|
| 12.
|
Durmowicz, A. G.,
Parks, W. C.,
Hyde, D. M.,
Mecham, R. P.,
and Stenmark, K. R.
(1994)
Am. J. Pathol.
145,
1411-1420[Abstract]
|
| 13.
|
Perhonen, M.,
Han, X.,
Wang, W.,
Karpakka, J.,
and Takala, T. E.
(1996)
J. Appl. Physiol.
80,
2226-2233[Abstract/Free Full Text]
|
| 14.
|
Ostadal, B.,
Kolar, F.,
Pelouch, V.,
and Widimsky, J.
(1995)
Physiol. Res.
44,
45-51[Medline]
[Order article via Infotrieve]
|
| 15.
|
Kim, S. B.,
Kang, S. A.,
Park, J. S.,
Lee, J. S.,
and Hong, C. D.
(1996)
Nephron.
72,
275-280[Medline]
[Order article via Infotrieve]
|
| 16.
|
Falanga, V.,
Martin, T. A.,
Takagi, H.,
Kirsner, R. S.,
Helfman, T.,
Pardes, J.,
and Ochoa, M. S.
(1993)
J. Cell. Physiol.
157,
408-412[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Hay, E. D.
(1991)
Collagen
, Plenum Press, New York, NY
|
| 18.
|
Batenburg, J. J.,
Otto-Verberne, C. J.,
Ten-Have-Opbroek, A. A.,
and Klazinga, W.
(1988)
Biochim. Biophys. Acta
960,
441-453[Medline]
[Order article via Infotrieve]
|
| 19.
|
Hoffman, E. C.,
Reyes, H.,
Chu, F. F.,
Sander, F.,
Conley, L. H.,
Brooks, B. A.,
and Hankinson, O.
(1991)
Science
252,
954-958[Abstract/Free Full Text]
|
| 20.
|
Ito, T.,
Kito, K.,
Adati, N.,
Mitsui, Y.,
Hagiwara, H.,
and Sakaki, Y.
(1994)
FEBS Lett.
351,
231-236[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Takahashi, Y.,
Oakes, S. M.,
Williams, M. C.,
Takahashi, S.,
Miura, T.,
and Joyce-Brady, M.
(1997)
Toxicol. Appl. Pharmacol.
143,
388-396[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Takahashi, Y.,
Takahashi, S.,
Yoshimi, T.,
Miura, T.,
Mochitate, K.,
and Kobayashi, T.
(1997)
Biochemical Pharmacol.
53,
1061-1064[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Barbu, V.,
and Dautry, F.
(1989)
Nucleic Acids Res.
17,
7115[Free Full Text]
|
| 24.
|
Berg, RA.
(1982)
Methods Enzymol.
82,
372-398
|
| 25.
|
Inayama, S.,
Shibata, T.,
Ohtsuki, J.,
and Saito, S.
(1978)
Keio J. Med.
27,
43-46[Medline]
[Order article via Infotrieve]
|
| 26.
|
Cesarone, C. F.,
Bolognesi, C.,
and Santi, L.
(1979)
Anal. Biochem.
100,
188-197[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Firth, J. D.,
Ebert, B. L.,
Pugh, C. W.,
and Ratcliffe, P. J.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
6496-6500[Abstract/Free Full Text]
|
| 28.
|
Ebert, B. L.,
Firth, J. D.,
and Ratcliffe, P. J.
(1995)
J. Biol. Chem.
270,
29083-29089[Abstract/Free Full Text]
|
| 29.
|
Pugh, C. W.,
O'Rourke, J. F.,
Nagao, M.,
Gleadle, J. M.,
and Ratcliffe, P. J.
(1997)
J. Biol. Chem.
272,
11205-11214[Abstract/Free Full Text]
|
| 30.
|
Semenza, G. L.
(1998)
J. Lab. Clin. Med.
131,
207-214[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Lok, C. N.,
and Ponka, P.
(1999)
J. Biol. Chem.
274,
24147-24152[Abstract/Free Full Text]
|
| 32.
|
Levene, C. I.,
and Bates, C. J.
(1976)
Biochim. Biophys. Acta
444,
446-452[Medline]
[Order article via Infotrieve]
|
| 33.
|
Turto, H.,
Lindy, H.,
Helin, P.,
Garbarsch, C.,
and Lorenzen, I. B.
(1979)
Atherosclerosis.
33,
379-384[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Ema, M.,
Hirota, K.,
Mimura, J.,
Abe, H.,
Yodoi, J.,
Sogawa, K.,
Poellinger, L.,
and Fujii-Kuriyama, Y.
(1999)
EMBO J.
18,
1905-1914[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Virbasius, C. A.,
Virbasius, J. V.,
and Scarpulla, R. C.
(1993)
Genes and Dev.
7,
2431-2445[Abstract/Free Full Text]
|
| 36.
|
Discher, D. J.,
Bishopric, N. H.,
Wu, X.,
Peterson, C. A.,
and Webster, K. A.
(1999)
J. Biol. Chem.
273,
26087-26093[Abstract/Free Full Text]
|
| 37.
|
O'Rourke, J. F.,
Pugh, C. W.,
Bartlett, S. M.,
and Ratcliffe, P. J.
(1996)
Eur. J. Biochem.
241,
403-410[Medline]
[Order article via Infotrieve]
|
| 38.
|
Beck, I.,
Ramirez, S.,
Weinmann, R.,
and Caro, J.
(1991)
J. Biol. Chem.
266,
15563-15566[Abstract/Free Full Text]
|
| 39.
|
Ikeda, E.,
Achen, M. G.,
Breier, G.,
and Risau, W.
(1995)
J. Biol. Chem.
270,
19761-19766[Abstract/Free Full Text]
|
| 40.
|
Czyzyk-Krzeska, M. F.,
and Beresh, J. E.
(1996)
J. Biol. Chem.
271,
3293-3299[Abstract/Free Full Text]
|
| 41.
|
Kivirikko, K. I.
(1998)
Adv. Enzy. Relat. Areas Mol. Biol.
72,
325-398[Medline]
[Order article via Infotrieve]
|
| 42.
|
Prockop, D. J.,
and Kivirikko, K. I.
(1995)
Annu. Rev. Biochem.
64,
403-434[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Myllyla, R.,
Kuutti-Savolainen, E. R.,
and Kivirikko, K. I.
(1978)
Biochem. Biophys. Res. Commun.
83,
441-448[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Brown-Augsburger, P.,
Chang, D.,
Rust, K.,
and Crouch, E. C.
(1996)
J. Biol. Chem.
271,
18912-18919[Abstract/Free Full Text]
|
| 45.
|
Arbeille, P.,
Maulik, D.,
Salihagic, A.,
Locatelli, A.,
Lansac, J.,
and Platt, L. D.
(1997)
Obstet. Gynecol.
90,
795-802[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Davila, R. M.,
deMello, D.,
and Crouch, E. C.
(1995)
Am. J. Physiol.
268,
L309-320[Abstract/Free Full Text]
|
| 47.
|
Wasowicz, M.,
Biczysko, W.,
Marszalek, A.,
Yokoyama, S.,
and Nakayama, I.
(1998)
Folia. Histochem. Cytobiol.
36,
3-13[Medline]
[Order article via Infotrieve]
|
| 48.
|
Brody, J. S.,
and Williams, M. C.
(1992)
Annu. Rev. Physiol.
54,
351-371[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Benita, H. Kikuchi, A. D. Smith, M. Q. Zhang, D. C. Chung, and R. J. Xavier
An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia
Nucleic Acids Res.,
June 2, 2009;
(2009)
gkp425v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. S. Brooks, G. P. Elvidge, L. Glenny, J. M. Gleadle, C. Liu, J. Ragoussis, T. G. Smith, N. P. Talbot, L. Winchester, P. H. Maxwell, et al.
Variations within oxygen-regulated gene expression in humans
J Appl Physiol,
January 1, 2009;
106(1):
212 - 220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Wouters, B. Pauwels, F. Lardon, and J. B. Vermorken
Review: Implications of In Vitro Research on the Effect of Radiotherapy and Chemotherapy Under Hypoxic Conditions
Oncologist,
June 1, 2007;
12(6):
690 - 712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Provot, D. Zinyk, Y. Gunes, R. Kathri, Q. Le, H. M. Kronenberg, R. S. Johnson, M. T. Longaker, A. J. Giaccia, and E. Schipani
Hif-1{alpha} regulates differentiation of limb bud mesenchyme and joint development
J. Cell Biol.,
May 7, 2007;
177(3):
451 - 464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Ke and M. Costa
Hypoxia-Inducible Factor-1 (HIF-1)
Mol. Pharmacol.,
November 1, 2006;
70(5):
1469 - 1480.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fahling, R. Mrowka, A. Steege, G. Nebrich, A. Perlewitz, P. B. Persson, and B. J. Thiele
Translational Control of Collagen Prolyl 4-Hydroxylase-{alpha}(I) Gene Expression under Hypoxia
J. Biol. Chem.,
September 8, 2006;
281(36):
26089 - 26101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Fandrey, T. A. Gorr, and M. Gassmann
Regulating cellular oxygen sensing by hydroxylation
Cardiovasc Res,
September 1, 2006;
71(4):
642 - 651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Grimmer, N. Balbus, U. Lang, T. Aigner, T. Cramer, L. Muller, B. Swoboda, and D. Pfander
Regulation of Type II Collagen Synthesis during Osteoarthritis by Prolyl-4-Hydroxylases: Possible Influence of Low Oxygen Levels
Am. J. Pathol.,
August 1, 2006;
169(2):
491 - 502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Chen, Y. H. Shen, X. Wang, J. Wang, Y. Gan, N. Chen, J. Wang, S. A. LeMaire, J. S. Coselli, and X. L. Wang
Human Prolyl-4-hydroxylase {alpha}(I) Transcription Is Mediated by Upstream Stimulatory Factors
J. Biol. Chem.,
April 21, 2006;
281(16):
10849 - 10855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fahling, R. Mrowka, A. Steege, P. Martinka, P. B. Persson, and B. J. Thiele
Heterogeneous Nuclear Ribonucleoprotein-A2/B1 Modulate Collagen Prolyl 4-Hydroxylase, {alpha} (I) mRNA Stability
J. Biol. Chem.,
April 7, 2006;
281(14):
9279 - 9286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. Wenger, D. P. Stiehl, and G. Camenisch
Integration of Oxygen Signaling at the Consensus HRE
Sci. Signal.,
October 18, 2005;
2005(306):
re12 - re12.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Shen, D. Nettleton, M. Jiang, S. K. Kim, and J. A. Powell-Coffman
Roles of the HIF-1 Hypoxia-inducible Factor during Hypoxia Response in Caenorhabditis elegans
J. Biol. Chem.,
May 27, 2005;
280(21):
20580 - 20588.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Blais, V. Filipenko, M. Bi, H. P. Harding, D. Ron, C. Koumenis, B. G. Wouters, and J. C. Bell
Activating Transcription Factor 4 Is Translationally Regulated by Hypoxic Stress
Mol. Cell. Biol.,
September 1, 2004;
24(17):
7469 - 7482.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Fajardo, L. Svensson, A. Bucht, and G. Pejler
Increased Levels of Hypoxia-sensitive Proteins in Allergic Airway Inflammation
Am. J. Respir. Crit. Care Med.,
September 1, 2004;
170(5):
477 - 484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wellmann, C. Buhrer, E. Moderegger, A. Zelmer, R. Kirschner, P. Koehne, J. Fujita, and K. Seeger
Oxygen-regulated expression of the RNA-binding proteins RBM3 and CIRP by a HIF-1-independent mechanism
J. Cell Sci.,
May 1, 2004;
117(9):
1785 - 1794.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Schmidt, F. Gerlach, A. Avivi, T. Laufs, S. Wystub, J. C. Simpson, E. Nevo, S. Saaler-Reinhardt, S. Reuss, T. Hankeln, et al.
Cytoglobin Is a Respiratory Protein in Connective Tissue and Neurons, Which Is Up-regulated by Hypoxia
J. Biol. Chem.,
February 27, 2004;
279(9):
8063 - 8069.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. O. Leonard, D. C. Cottell, C. Godson, H. R. Brady, and C. T. Taylor
The Role of HIF-1{alpha} in Transcriptional Regulation of the Proximal Tubular Epithelial Cell Response to Hypoxia
J. Biol. Chem.,
October 10, 2003;
278(41):
40296 - 40304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Salnikow, T. Davidson, Q. Zhang, L. C. Chen, W. Su, and M. Costa
The Involvement of Hypoxia-inducible Transcription Factor-1-dependent Pathway in Nickel Carcinogenesis
Cancer Res.,
July 1, 2003;
63(13):
3524 - 3530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. O. Bates and R. O. P. Jones
The Role of Vascular Endothelial Growth Factor in Wound Healing
International Journal of Lower Extremity Wounds,
June 1, 2003;
2(2):
107 - 120.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ivan, T. Haberberger, D. C. Gervasi, K. S. Michelson, V. Gunzler, K. Kondo, H. Yang, I. Sorokina, R. C. Conaway, J. W. Conaway, et al.
Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor
PNAS,
October 15, 2002;
99(21):
13459 - 13464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bernaudin, Y. Tang, M. Reilly, E. Petit, and F. R. Sharp
Brain Genomic Response following Hypoxia and Re-oxygenation in the Neonatal Rat. IDENTIFICATION OF GENES THAT MIGHT CONTRIBUTE TO HYPOXIA-INDUCED ISCHEMIC TOLERANCE
J. Biol. Chem.,
October 11, 2002;
277(42):
39728 - 39738.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. WENGER
Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression
FASEB J,
August 1, 2002;
16(10):
1151 - 1162.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Masamune, K. Kikuta, M. Satoh, Y. Sakai, A. Satoh, and T. Shimosegawa
Ligands of Peroxisome Proliferator-activated Receptor-gamma Block Activation of Pancreatic Stellate Cells
J. Biol. Chem.,
January 4, 2002;
277(1):
141 - 147.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F. Yu, S. B. White, Q. Zhao, and F. S. Lee
HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation
PNAS,
August 14, 2001;
98(17):
9630 - 9635.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Clifford, M. E. Cockman, A. C. Smallwood, D. R. Mole, E. R. Woodward, P. H. Maxwell, P. J. Ratcliffe, and E. R. Maher
Contrasting effects on HIF-1{{alpha}} regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease
Hum. Mol. Genet.,
May 1, 2001;
10(10):
1029 - 1038.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ivan, K. Kondo, H. Yang, W. Kim, J. Valiando, M. Ohh, A. Salic, J. M. Asara, W. S. Lane, and W. G. Kaelin Jr.
HIFalpha Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing
Science,
April 20, 2001;
292(5516):
464 - 468.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. K. Graven, C. Molvar, J. S. Roncarati, B. D. Klahn, S. Lowrey, and H. W. Farber
Identification of protein disulfide isomerase as an endothelial hypoxic stress protein
Am J Physiol Lung Cell Mol Physiol,
May 1, 2002;
282(5):
L996 - L1003.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|